SCHEMBL18075813

SCHEMBL18075813

Cc1c(-c2ccccc2)nc2ccccc2c1OC(=O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 4/20 0.61
TSHR P16473 2/20 0.61
DHODH Q02127 9/20 0.58
MAPT P10636 1/20 0.50
TACR3 P29371 5/20 0.48
LMNA P02545 1/20 0.48
CYP2C19 P33261 2/20 0.47
CYP2D6 P10635 1/20 0.47
TACR2 P21452 2/20 0.46
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 1/20 0.46
TP53 P04637 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
NFKB1 P19838 1/20 0.46
MAPK1 P28482 1/20 0.46
BLM P54132 1/20 0.46
PMP22 Q01453 1/20 0.46
KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27583476 0.90 PDE10A (0.60) PDE10ATSHRDHODHMAPTTACR3
SCHEMBL17594006 0.86 DHODH (0.62) PDE10ATSHRDHODHMAPTLMNA
SCHEMBL18075793 0.86 PDE10A (0.52) PDE10ATSHRDHODHMAPT
SCHEMBL17594351 0.85 PTGFR (0.53) ALDH1A1
SCHEMBL17594300 0.84 PTGFR (0.51) PDE10ATSHRDHODH
SCHEMBL17594353 0.84 DHODH (0.64) PDE10ATSHRDHODHLMNAALDH1A1
SCHEMBL17593891 0.84 PTGFR (0.51) PDE10ATSHRDHODHALDH1A1CYP2C9
SCHEMBL17594047 0.84 DHODH (0.64) PDE10ADHODH
SCHEMBL5497084 0.83 DHODH (0.60) PDE10ATSHRDHODHTACR3LMNA
SCHEMBL18075863 0.83 PTGFR (0.52) PDE10ATSHRDHODHMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3271334-A1 SUBSTITUTED N-BICYCLO-2-ARYL-QUINOLIN-4-CARBOXAMIDES AND USE THEREOF Bayer Pharma Aktiengesellschaft (DE) 2018-01-24 EP disclosed
WO-2016146602-A1 SUBSTITUTED N-BICYCLO-2-ARYL-QUINOLIN-4-CARBOXAMIDES AND USE THEREOF BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-09-22 WO disclosed